Abstract
Somaliland experienced a large dengue fever outbreak between 2023 and 2024. National laboratory surveillance identified 4971 clinically suspected cases that underwent testing (‘tested probable cases’), of which 1703 were confirmed using rapid diagnostic tests. Three deaths were reported. Cases spanned five regions of Somaliland, with 74% in Marodijeh. As surveillance data were restricted to public-sector facilities, these findings represent a lower-bound estimate of true dengue transmission.
Contribution: We highlight the utility of the new laboratory surveillance and the need for mitigating dengue risks amid climatic fluctuations.
Keywords: dengue; disease outbreaks; rapid diagnostic tests; epidemiology; Eastern Africa; humans.
Background
Dengue fever (DF), transmitted primarily by the Aedes aegypti mosquito, has significantly impacted Eastern Africa and the Middle East since its re-emergence in the late 20th century, with three serotypes now circulating (Dengue virus, DENV-1, DENV-2 and DENV-3).1,2,3 Somaliland is a self-declared republic, a partially recognised state in the Horn of Africa that declared independence from Somalia in May 1991. Somaliland’s first reported DF outbreak occurred in its capital city, Hargeisa, during 1985–1987.4 No further outbreaks were reported1 until October 2022, when the Somaliland Ministry of Health Development (MoHD) declared a DF outbreak5 concurrent with outbreaks in neighbouring regions of Somalia.6,7 By February 2023, fever cases at public healthcare facilities in Somaliland declined and remained low (Appendix 1 Figure 1-A1), until 14 September 2023 when a new cluster of probable dengue patients was identified at a hospital near Hargeisa. Following confirmation by the National Public Health Laboratory (NPHL) using reverse transcriptase polymerase chain reaction (RT-PCR), MoHD declared a new DF outbreak on 03 October 2023 and initiated control measures, including spraying for vector reduction, risk communication and community engagement and training of healthcare personnel in clinical management. On 21 October 2023, MoHD requested assistance from the United Kingdom (UK) Public Health Rapid Support Team to conduct a joint epidemiologic investigation.
Methods
Case definition
A ‘probable DF case’ was defined as having fever and ≥ 2 of the following symptoms: nausea/vomiting, rash, aches and pains, tourniquet test positive, leukopenia, any warning sign,8 identified at a healthcare facility in Somaliland, with symptom onset between 01 September 2023 and 30 June 2024. A ‘confirmed case’ was a probable case with a positive result for immunoglobulin M (IgM) or non-structural protein 1 (NS1) antigen in a single serum sample using a rapid diagnostic test (RDT). Sample collection or reporting date was assumed to represent the symptom onset date if unavailable.
Case finding and data source
We collected morbidity data from NPHL and mortality data from MoHD. From September 2023, NPHL procured a limited supply of dengue RDTs (SD Bioline Dengue Ag/Ab [NS1/IgM]) from the World Health Organization (WHO) and trained personnel in public-sector referral health centres and hospitals to test probable patients and report all tests to a newly established surveillance system with data on: date of sample collection, type and result of dengue test, patient’s gender, age, place of residence, presenting healthcare facility, presenting symptoms and date of symptom onset. Only probable cases that underwent laboratory testing were included in the system; thus, our study population consisted of only tested probable cases (all ‘cases’), which were subsequently classified as confirmed (RDT positive) or non-confirmed (RDT negative). Data were received from seven of the 23 districts spanning five of Somaliland’s six regions (Figure 1a); Sool Region did not report dengue testing because of an unstable situation. The MoHD collated the number of dengue-related deaths retrospectively.
 |
FIGURE 1: Distribution of tested dengue fever cases†, Somaliland, 01 September 2023 – 30 June 2024‡. (a) Somaliland’s district borders are shown, and districts are coloured according to Somaliland administrative regions. Districts reporting dengue fever cases are darker, with district names labelled: Borama and Lughaya in Awdal Region, Gabiley and Hargeisa in Marodijeh, Berbera in Sahil, Erigavo in Sanag and Burao in Togdheer. (b) Weekly dengue fever cases in a stacked bar chart for all Somaliland regions over the study period. (c) Weekly dengue fever test positivity trend over the study period. (d) Monthly incidence of dengue fever by districts in Somaliland. |
|
Data analysis
We report the attack rate (number of tested probable cases or confirmed cases/population based on the 2023 MoHD Population Estimation Survey, Appendix 1 Table 1-A1) and the case fatality rate (CFR) (number of dengue-related deaths/number of tested probable cases). All analyses were conducted using R version 4.5.0 (Vienna, Austria).
Ethical considerations
Ethical approval was not required, as analyses were part of monitoring and the response to an ongoing outbreak. This investigation was conducted under the leadership and oversight of the Somaliland MoHD, which has the legal mandate for public health surveillance and outbreak response. Data were collected as part of routine public health monitoring, and all activities adhered to national guidelines on confidentiality, data protection and responsible use of health information. This article followed all ethical standards for research without direct contact with human or animal subjects.
Results
Between 01 September 2023 and 30 June 2024, Somaliland NPHL documented 4971 tested probable DF cases, with 1703 (34.2%) confirmed by RDT (Table 1), and a small subset (n = 12) underwent RT-PCR at the start of the outbreak (2 negatives and 10 positives). The outbreak predominantly affected younger adults and children (median age of all cases: 23 years; interquartile range: 10–35). Overall DF attack rate was 109 cases per 100 000 population over the 10-month period, with 37.2 confirmed cases per 100 000. Ministry of Health Development (MoHD) reported three DF-related deaths (CFR 0.06%).
| TABLE 1: Dengue fever patient characteristics by rapid diagnostic test† positivity, Somaliland, 01 September 2023 – 30 June 2024. |
The outbreak peaked in mid-November 2023 with 436 new cases per week, predominantly from the capital region of Marodijeh (Figure 1a–b). Cases dropped to fewer than 100 weekly cases in early 2024. Between January 2024 and May 2024, the northeastern regions of Sahil and Sanag were most affected. Marodijeh experienced a second surge in June 2024. Throughout the outbreak, Togdheer and Awdal regions reported only intermittent cases.
Patient characteristics varied by time and region (Appendix 1 Table 2-A1). Marodijeh saw older cases in the 2024 wave than in the 2023 wave (median age 25 years vs 18 years, Mann–Whitney test p < 0.001). Other regions reported median ages ranging from 25 years to 32 years. Gender distributions were relatively balanced (48.5% female). Similar patterns were observed among confirmed cases (Appendix 1 Table 3-A1).
Rapid diagnostic testing began in September 2023 in Marodijeh and expanded to all regions except Sool by November 2023. During October 2023 – November 2023, 84% of febrile patients reported through public facilities were tested (Appendix 1 Figure 1-A1). Overall, one third of probable cases tested positive for dengue (Table 1, Figure 1c). Older patients were more likely to test positive (chi-squared trend test: p = 0.004). Test positivity exceeded 40% during the first 2 months of the outbreak and as cases resurged in May 2024 – June 2024. Frequent testing gaps were observed in Awdal, Sahil, Sanag and Togdheer regions (Appendix 1 Figure 2-A1), coinciding with reported shortages of RDT kits.
Discussion
This investigation describes extensive and recurring dengue transmission in Somaliland from September 2023 to June 2024 with 4971 tested probable cases and three reported deaths. Concurrent transmission was reported in neighbouring Ethiopia9,10 and Yemen.2 While clinical features of the second wave of this outbreak have previously been described,11 here we show that transmission was sustained across multiple waves for almost a year and spread across multiple regions. The presence of cases across all age groups, matching the population’s age structure, and the low CFR (0.06%) suggest that most cases represent primary dengue infections; however, this remains a hypothesis in the absence of serological evidence. As subsequent infections with different dengue serotypes are more likely to result in serious clinical manifestations, this leaves Somaliland vulnerable to more severe future outbreaks.
Recent extreme climatic conditions in Eastern Africa may have contributed to changes in dengue risk, as high rainfall or droughts that lead to standing water in open containers increase Aedes Aegypti egg-laying habitat.12 Historically, Somaliland observes two rainy seasons: March–June [gu] and October–November [deyr]. During the 2023 deyr, rains were exceptionally heavy,13 coinciding with the outbreak’s onset. Rainfall deficits in the 2024 gu season14 coincided with a new peak in dengue cases in June. Although causality cannot be inferred solely from the observed temporal overlap between rainfall patterns and dengue incidence, these fluctuations underscore the urgent need for integrated surveillance that combines entomological and meteorological data to better understand dengue transmission dynamics in the region. Drought and flood response planning in Somaliland must specifically address potential increases in dengue risk and identify strategies for mitigation.
The investigation has several limitations. Reliance on NPHL’s surveillance of laboratory-tested probable cases led to underreporting of milder cases, cases from areas with limited healthcare access (one-third of the population lives in nomadic settlements, Appendix 1 Table 4-A1) and cases presenting to primary-care facilities, which had very limited or no access to case detection training or RDT kits. The changing availability of RDT affected clinical criteria for testing; no data were available to estimate the testing fraction over time. Syndromic surveillance will complement RDT testing and mitigate this bias in resource-constrained settings. Only 12 cases were tested by RT-PCR; reliance on RDT testing may have introduced diagnostic misclassification, as IgM cross-reactivity with other flaviviruses and antibody persistence can result in false-positive RDTs, leading to an overestimation of the true burden of dengue among tested cases. The lack of viral serotyping precludes further insights into transmission dynamics and disease severity. Additionally, NPHL did not have access to private facility data; the 2020 Somaliland Health and Demographic Survey reported that residents were 50% more likely to visit private facilities than public ones when sick, and that healthcare-seeking patterns varied by urbanicity, region and wealth.15 Our figures likely represent a lower-bound estimate of the scale of the DF outbreak in Somaliland. Demographic differences between patients in public and private facilities further constrained the representativeness of NPHL data. These limitations preclude interpreting regional heterogeneity in disease attack rates and test positivity rates as definitive indicators of dengue transmission intensity. Caution is also required when assessing transmission dynamics given the incompleteness of symptom onset data; nonetheless, sensitivity analyses limited to cases with complete symptom onset dates revealed no substantial distortions to reported trends (Appendix 1 Figure 3-A1). Furthermore, the retrospective reporting of dengue-related deaths and the lack of information on patient outcome in laboratory surveillance may have resulted in an underestimation of the true CFR in public facilities; a CFR of 0.06% is low compared with those reported by some other regions (0.01% – 1%).1 Lastly, the absence of vector and serotype surveillance and reporting of tests for other pathogens of probable cases who were RDT negative prevented more comprehensive analyses of outbreak dynamics and potential changes in severity.
Despite these limitations, the investigation demonstrates the utility of the new laboratory surveillance system in Somaliland during its first year of operation. Strengthening an integrated DF surveillance system will not only preserve institutional memory but also provide insights into how socioeconomic and climatic factors amplify dengue risks. Given the large nomadic population, understanding the spatiotemporal patterns of disease burden is crucial for informing more tailored interventions to mitigate dengue transmission.
Acknowledgements
We thank healthcare facilities in Somaliland for caring for dengue patients and for reporting data to the National Public Health Laboratory surveillance. Hibo Asad thanks partners in the Somaliland MoHD for their collaboration and operational colleagues in the UK Public Health Rapid Support Team and Foreign, Commonwealth & Development Office for supporting her deployment from December 2023 to March 2024.
Information in this article has previously been presented in this preprint: medRxiv 2025.06.13.25329553; https://doi.org/10.1101/2025.06.13.25329553.16
We used GitHub Copilot to assist in generating R code for data cleaning, analysis and visualisation. Once the article was drafted and reviewed by coauthors, we removed data- and context-specific details from selected sentences to prompt Perplexity.ai to suggest ways to shorten and improve them. All codes and article revisions made with the assistance of these AI tools were subsequently reviewed by the coauthors.
Competing interests
The authors reported that they received funding from the Department of Health and Social Care jointly run by the UK Health Security Agency and the London School of Hygiene & Tropical Medicine, which may be affected by the research reported in the enclosed publication. The author has disclosed those interests fully and has implemented an approved plan for managing any potential conflicts arising from their involvement. The terms of these funding arrangements have been reviewed and approved by the affiliated university in accordance with its policy on objectivity in research.
CRediT authorship contribution
Hibo Asad: Conceptualisation, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualisation, Writing – original draft, Writing – review & editing. Amal Ali: Conceptualisation, Investigation, Methodology, Project administration, Writing – review & editing. Ahmed Hashi: Conceptualisation, Data curation, Investigation, Methodology, Resources, Validation, Writing – review & editing. Idhil Hirsi: Investigation, Validation, Visualisation, Writing – original draft. Mahdi D. Bahdoon: Conceptualisation, Data curation, Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review & editing. Victor Del Rio Vilas: Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review & editing. Oliver J. Brady: Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing. Hilary Bower: Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review & editing. Farhana Haque: Investigation, Methodology, Resources, Supervision, Writing – review & editing. Ruoran Li: Conceptualisation, Formal analysis, Investigation, Methodology, Software, Supervision, Validation, Visualisation, Writing – original draft, Writing – review & editing. Mohamed A. Hergeye: Conceptualisation, Data curation, Funding acquisition, Investigation, Project administration, Resources, Supervision, Validation, Writing – review & editing. All authors reviewed the article, contributed to the discussion of results, approved the final version for submission and publication and take responsibility for the integrity of its findings.
Hibo Asad and Amal Ali contributed equally and are co-first authors of this article. Ruoran Li and Mohamed A. Hergeye contributed equally and are co-senior authors.
Funding information
The UK Public Health Rapid Support Team is funded by UK Aid from the Department of Health and Social Care and is jointly run by the UK Health Security Agency and the London School of Hygiene & Tropical Medicine.
Data availability
The data analysed in this study are national outbreak response records and contain sensitive, line-list epidemiological information. Because of the potential for re-identification of individuals and the confidential nature of public health surveillance data, the raw dataset cannot be made publicly available. Requests for access to the data for research purposes should be directed to the Somaliland Ministry of Health Development – Email: info.mohd@sldgov.org; Phone (Emergency/Call Centre): 988 or +252634200882; Address: Road Number 1, Next to Hargeisa Hospital, Hargeisa, Somaliland. Access may be granted subject to a formal data-sharing agreement by the relevant authorities.
Disclaimer
The views and opinions expressed in this article are those of the authors and are the product of professional research. They do not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article’s results, findings and content.
References
- Humphrey JM, Cleton NB, Reusken CBEM, Glesby MJ, Koopmans MPG, Abu-Raddad LJ. Dengue in the Middle East and North Africa: A systematic review. PLoS Negl Trop Dis. 2016;10(12):e0005194. https://doi.org/10.1371/journal.pntd.0005194
- Edrees WH, Al-Shehari WA, Al-Haddad AM, Alrahabi LM, Al-Haddad OS, Al-Halani AA. Dengue fever in Yemen: A five-year review, 2020–2024. BMC Infect Dis. 2025;25(1):28. https://doi.org/10.1186/s12879-024-10429-6
- Bosa HK, Montgomery JM, Kimuli I, Lutwama JJ. Dengue fever outbreak in Mogadishu, Somalia 2011: Co-circulation of three dengue virus serotypes. Int J Infect Dis. 2014;21(Suppl. 1):3. https://doi.org/10.1016/j.ijid.2014.03.412
- Botros BAM, Watts DM, Soliman AK, et al. Serological evidence of dengue fever among refugees, Hargeysa, Somalia. J Med Virol. 1989;29(2):79–81. https://doi.org/10.1002/jmv.1890290202
- Nour HM, Ahmed MA, Kahsay AB. Sero-prevalence of dengue virus infection and associated factors among patients with febrile illness attending at Edna Adan University Hospital. Hargeisa, Somaliland, 2022: A cross-sectional study. J Womens Health Care. 2023;12(7):1–5.
- Mohamed MA, Hassan NY, Osman MM, et al. Epidemiological investigation of dengue fever outbreak and its socioeconomic determinants in Banadir region, Somalia. BMC Infect Dis. 2024;24(1):393. https://doi.org/10.1186/s12879-024-09276-2
- Jama SS, Abshir SN, Jama JS, Abdi MM. Retrospective study on the dengue fever outbreak in Puntland State, Somalia. BMC Infect Dis. 2024;24(1):735. https://doi.org/10.1186/s12879-024-09552-1
- World Health Organization. Dengue guidelines, for diagnosis, treatment, prevention and control [homepage on the Internet]. 2009 [cited 2024 Aug 9]. Available from: https://www.who.int/publications/i/item/9789241547871
- Africa CDC. Africa CDC Weekly Event Based Surveillance Report, December 2023 [homepage on the Internet]. 2023 [cited 2024 Aug 9]. Available from: https://africacdc.org/download/africa-cdc-weekly-event-based-surveillance-report-december-2023/
- Africa CDC. Africa CDC Epidemic Intelligence Weekly Report, 02 August 2024 [homepage on the Internet]. 2024 [cited 2024 Aug 9]. Available from: https://africacdc.org/download/africa-cdc-weekly-event-based-surveillance-report-august-2024/
- Yosef DK, Ismail AS, Awil BS, Hassan HA, Hassan MA. Epidemiology of dengue fever in Somaliland: Clinical features, and serological patterns from a retrospective study. BMC Infect Dis. 2025;25(1):179. https://doi.org/10.1186/s12879-025-10558-6
- Sintayehu DW, Tassie N, De Boer WF. Present and future climatic suitability for dengue fever in Africa. Infect Ecol Epidemiol. 2020;10(1):1782042. https://doi.org/10.1080/20008686.2020.1782042
- Somalia Water and Land Information Management. Review of Deyr 2023 rainfall performance, Julal status, Gu outlook and implications on livelihoods over Somalia [homepage on the Internet]. 2024 [cited 2024 Aug 16]. Available from: https://www.faoswalim.org/resources/site_files/Deyr_2023_rainfall_review_and_impacts%20on_livelihood_0.pdf
- Somalia Water and Land Information Management. Review of Gu 2024 rainfall performance, Hagaa outlook and implications on livelihoods over Somalia [homepage on the Internet]. 2024 [cited 2024 Aug 16]. Available from: https://www.faoswalim.org/resources/site_files/Gu%202024%20Rainfall_performance_review_and_Impacts_on_Livelihood.pdf
- Central Statistics Department, Ministry of Planning and National Development, Somaliland Government. The Somaliland Health and Demographic Survey 2020. Hargeisa: Central Statistics Department, Ministry of Planning and National Development, Somaliland Government; 2020.
- Asad H, Ali A, Hashi A, et al. An outbreak investigation of a large dengue fever outbreak in Somaliland, 2023–2024. medRxiv. https://doi.org/10.1101/2025.06.13.25329553
Appendix 1
| TABLE 1-A1: Population size estimates in Somaliland’s districts, 2023. |
| TABLE 2-A1: Characteristics of tested dengue fever cases* by region of residence, Somaliland, 01 September 2023 – 30 June 2024. |
 |
FIGURE 1-A1: Weekly number of fever cases reported to Somaliland’s Health Management Information System†, tested probable dengue fever cases and laboratory-confirmed cases‡, Somaliland, 26 November 2022 – 30 June 2024. (a) Fever cases reported to Somaliland’s Health Management Information System. (b) Tested probable dengue fever cases. (c) Laboratory-confirmed cases. |
|
| TABLE 3-A1: Characteristics of confirmed dengue fever cases†, Somaliland regions, 01 September 2023 – 30 June 2024. |
 |
FIGURE 2-A1: Trends in volume and positivity† of laboratory samples tested for dengue using rapid diagnostic tests, by region of patient residence‡, Somaliland, 01 September 2023 – 30 June 2024§. (a) Somaliland; (b) Region: Awdal; (c) Region: Marodijeh; (d) Region: Sahil; (e) Region: Sanag and (f) Region: Togdheer. |
|
 |
FIGURE 3-A1: Weekly number of dengue fever cases by case status and certainty of symptom onset date†, Somaliland, 01 September 2023 – 30 June 2024. (a) Confirmed cases, known onset week (n = 675), (b) Confirmed cases, all cases (n = 1703), (c) Tested probable cases, known onset week (n = 1944), (d) Tested probable cases, all cases (n = 4971). |
|
| TABLE 4-A1: Somaliland’s population by type of residence, 2016. |
|